Logo image of CPSH

CPS TECHNOLOGIES CORP (CPSH) Stock Fundamental Analysis

NASDAQ:CPSH - Nasdaq - US12619F1049 - Common Stock - Currency: USD

1.61  -0.1 (-5.85%)

After market: 1.6101 +0 (+0.01%)

Fundamental Rating

3

Taking everything into account, CPSH scores 3 out of 10 in our fundamental rating. CPSH was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. While CPSH has a great health rating, there are worries on its profitability. CPSH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CPSH had negative earnings in the past year.
CPSH had a negative operating cash flow in the past year.
CPSH had positive earnings in 4 of the past 5 years.
Of the past 5 years CPSH 4 years had a positive operating cash flow.
CPSH Yearly Net Income VS EBIT VS OCF VS FCFCPSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.41%, CPSH is doing worse than 68.33% of the companies in the same industry.
The Return On Equity of CPSH (-12.95%) is worse than 62.50% of its industry peers.
Industry RankSector Rank
ROA -10.41%
ROE -12.95%
ROIC N/A
ROA(3y)11.1%
ROA(5y)7.43%
ROE(3y)15.31%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
CPSH Yearly ROA, ROE, ROICCPSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

CPSH's Profit Margin has improved in the last couple of years.
CPSH's Operating Margin has improved in the last couple of years.
CPSH has a Gross Margin of 5.93%. This is amonst the worse of the industry: CPSH underperforms 88.33% of its industry peers.
In the last couple of years the Gross Margin of CPSH has grown nicely.
CPSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.93%
OM growth 3Y12.26%
OM growth 5YN/A
PM growth 3Y4.49%
PM growth 5YN/A
GM growth 3Y7.43%
GM growth 5Y12.94%
CPSH Yearly Profit, Operating, Gross MarginsCPSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

7

2. Health

2.1 Basic Checks

CPSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CPSH has been increased compared to 1 year ago.
Compared to 5 years ago, CPSH has more shares outstanding
CPSH has a better debt/assets ratio than last year.
CPSH Yearly Shares OutstandingCPSH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
CPSH Yearly Total Debt VS Total AssetsCPSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

CPSH has an Altman-Z score of 3.23. This indicates that CPSH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CPSH (3.23) is comparable to the rest of the industry.
There is no outstanding debt for CPSH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.23
ROIC/WACCN/A
WACC9.05%
CPSH Yearly LT Debt VS Equity VS FCFCPSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 3.99 indicates that CPSH has no problem at all paying its short term obligations.
CPSH has a better Current ratio (3.99) than 70.00% of its industry peers.
A Quick Ratio of 2.78 indicates that CPSH has no problem at all paying its short term obligations.
CPSH has a better Quick ratio (2.78) than 69.17% of its industry peers.
Industry RankSector Rank
Current Ratio 3.99
Quick Ratio 2.78
CPSH Yearly Current Assets VS Current LiabilitesCPSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CPSH have decreased strongly by -237.84% in the last year.
CPSH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.20% yearly.
CPSH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.54%.
The Revenue has been growing slightly by 5.01% on average over the past years.
EPS 1Y (TTM)-237.84%
EPS 3Y10.2%
EPS 5YN/A
EPS Q2Q%-817.9%
Revenue 1Y (TTM)-18.54%
Revenue growth 3Y9.7%
Revenue growth 5Y5.01%
Sales Q2Q%-32.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPSH Yearly Revenue VS EstimatesCPSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
CPSH Yearly EPS VS EstimatesCPSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CPSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CPSH Price Earnings VS Forward Price EarningsCPSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPSH Per share dataCPSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CPSH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CPS TECHNOLOGIES CORP

NASDAQ:CPSH (2/21/2025, 8:10:45 PM)

After market: 1.6101 +0 (+0.01%)

1.61

-0.1 (-5.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)03-11 2025-03-11
Inst Owners21.24%
Inst Owner Change-12.51%
Ins Owners12.24%
Ins Owner Change-0.5%
Market Cap23.39M
Analysts0
Price TargetN/A
Short Float %2.15%
Short Ratio3.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.07
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS1.51
BVpS1.06
TBVpS1.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.41%
ROE -12.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.93%
FCFM N/A
ROA(3y)11.1%
ROA(5y)7.43%
ROE(3y)15.31%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y12.26%
OM growth 5YN/A
PM growth 3Y4.49%
PM growth 5YN/A
GM growth 3Y7.43%
GM growth 5Y12.94%
F-Score3
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 209.33%
Cap/Sales 4.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.99
Quick Ratio 2.78
Altman-Z 3.23
F-Score3
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)117.72%
Cap/Depr(5y)101.2%
Cap/Sales(3y)2.18%
Cap/Sales(5y)2.07%
Profit Quality(3y)77.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-237.84%
EPS 3Y10.2%
EPS 5YN/A
EPS Q2Q%-817.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.54%
Revenue growth 3Y9.7%
Revenue growth 5Y5.01%
Sales Q2Q%-32.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-256.85%
EBIT growth 3Y23.14%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-270.66%
FCF growth 3Y-25.9%
FCF growth 5YN/A
OCF growth 1Y-181.9%
OCF growth 3Y-8.78%
OCF growth 5YN/A